Claudin 1 Mediates TNFα-Induced Gene Expression and Cell Migration in Human Lung Carcinoma Cells

Epithelial-mesenchymal transition (EMT) is an important mechanism in carcinogenesis. To determine the mechanisms that are involved in the regulation of EMT, it is crucial to develop new biomarkers and therapeutic targets towards cancers. In this study, when TGFβ1 and TNFα were used to induce EMT in human lung carcinoma A549 cells, we found an increase in an epithelial cell tight junction marker, Claudin 1. We further identified that it was the TNFα and not the TGFβ1 that induced the fibroblast-like morphology changes. TNFα also caused the increase in Claudin-1 gene expression and protein levels in Triton X-100 soluble cytoplasm fraction. Down-regulation of Claudin-1, using small interfering RNA (siRNA), inhibited 75% of TNFα-induced gene expression changes. Claudin-1 siRNA effectively blocked TNFα-induced molecular functional networks related to inflammation and cell movement. Claudin-1 siRNA was able to significantly reduce TNF-enhanced cell migration and fibroblast-like morphology. Furthermore, over expression of Claudin 1 with a Claudin 1-pcDNA3.1/V5-His vector enhanced cell migration. In conclusion, these observations indicate that Claudin 1 acts as a critical signal mediator in TNFα-induced gene expression and cell migration in human lung cancer cells. Further analyses of these cellular processes may be helpful in developing novel therapeutic strategies.


Introduction
Inflammatory mediators are important constituents of local environment for tumors, and evidences suggest that they are closely linked to cancer and inflammation [1]. For instance, many chronic inflammatory diseases are associated with greater risk of cancer [2]. One of the key mediators implicated in inflammationassociated cancer is tumor necrosis factor alpha (TNFa) [3]. Although TNFa was first identified for its ability to induce rapid hemorrhagic necrosis of experimental cancers, TNFa is now known to be produced in cancer cells as an endogenous tumor promoter [2,3]. Animal model studies demonstrate that TNFa has pro-cancer actions [4,5]. TNFa2/2 and TNFR12/2 mice are resistant to chemically induced carcinogenesis in the skin [6]. TNFR12/2 mice are resistant to chemical carcinogenesis in the liver [7], and in the development of liver metastasis in experimental colon cancer [8]. Furthermore, TNFa is frequently detected in human cancers with poor prognosis, such as ovarian, renal and breast cancers [9]. TNFa has been suggested as a target for renal-cell carcinoma treatment [10].
The Claudin family of proteins consists of 24 members and plays an integral role in the formation and function of tight junctions [20,21]. Claudin family members interact with each other through homo-and heterophilic interactions [21,22]. As TJ proteins, Claudins are crucial for the maintenance of cellular polarity and paracellular transportation of molecules. Claudin proteins can be up-regulated and mis-localized in cancer cells [21]. The expression of Claudin 1 increases during tumorigenesis of colon cancer [23], melanoma [24], oral squamous cell carcinoma [25] and hepatocellular carcinoma [26].
In the present study, human lung carcinoma A549 cells were treated with TNFa and TGFb1 to induce EMT. The expression of Claudin 1 was increased in response to TNFa challenge. Further studies indicated that Claudin 1 plays a crucial role in TNFainduced gene expression and cell migration in human lung carcinoma cells.

Cell line, antibodies and other reagents
Human lung adenocarcinoma A549 cells and MDCK cells were grown in DMEM medium supplied with 10% fetal bovine serum, 1% penicillin-streptomycin, and 1% glutamine. Cells were cultured in a standard humidified incubator at 37uC with 5% CO 2 .
Antibodies for ZO-1, E-Cadherin, Occludin and Claudin-1 were from Zymed Laboratories (S. San Francisco, CA). Antibody for Vimentin was from Cell Signaling Technology (Beverly, MA). Antibody for GAPDH was from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidase (HRP)-conjugated goat antimouse and anti-rabbit secondary antibodies were from Amersham Pharmacia Biotech (Piscataway, NJ). Alexa Fluor 488 labeled goat anti-mouse and anti-rabbit secondary antibodies, rhodamine phalloidin, and Hoechst dye 33342 were from Invitrogen (Carlsbad, CA). Human TNFa was from R&D Systems Inc.

Immunofluorescent staining and microscopy
Cells were stained as previously described [27][28][29]. A549 cells were cultured on glass coverslips (VWR, Mississauga, Canada). After different treatments, cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked with 1% BSA, stained with designated antibodies, rhodamine phalloidin and Hoechst dye 33342. After gentle washing, coverslips were mounted on glass slides with Dako fluorescence mounting medium (Dako, Mississauga, Canada). Slides were examined as previously described [27][28][29]. Isotype-matched mouse or rabbit IgG were used as negative control with the same dilutions as the primary antibodies. The combined treatment of TNFa (20 ng/ml) and TGFb1 (10 ng/ml) for 72 h induced morphological alterations characterized as fibroblast-like cells. (B) TNFa and TGFb1 treatment reduced expression of E-Cadherin at cell-to-cell contacts, and increased formation of F-actin stress fibers. Cells were immunostained with an anti-E-Cadherin antibody and counterstained F-actin and nuclei with rhodamine phalloidin and Hoechst 33342, respectively. (C) The redistribution of E-cadherin after TGFb and TNFa treatment from the cellto-cell contacts to cytosol was further demonstrated with confocal microscopy at higher maginification. (D) The 72 h treatment with TNFa and TGFb1 decreased expressions of E-Cadherin and Occludin, epithelial markers, and increased expressions of Vimentin, a mesenchymal marker, in A549 cells. Surprisingly, the expression of Claudin 1, an epithelial marker, was increased as analyzed by western blotting. doi:10.1371/journal.pone.0038049.g001

Protein studies
Immunoblotting experiments were performed according to procedures described previously [30][31][32][33]. Triton X-100 soluble and insoluble protein fractions were prepared as described by Nishiyama and coworkers [34]. Briefly, cells were lysed with modified radioimmune precipitation assay buffer containing 1% Triton X-100. Cell lysate was centrifuged (12,000 rpm for 10 min at 4uC), and the supernatant was collected as the Trinton Xsoluble fraction. The remaining pellet was resuspended in 60 ml of lysis buffer containing 1% SDS. The resulting suspension was centrifuged (12,000 rpm for 10 min at 4uC) and the supernatant was collected as the Triton-X insoluble fraction.

Real-time quantitative RT-PCR
The qRT-PCR primers used for human Claudin-1 were 59-GCGCGATATTTCTTCTTGCAGG-39 (Forward) and 59-TTCGTACCTGGCATTGACTGG-39 (Reverse) [35]. The primers used for human succinate dehydrogenase complex subunit A (SDHA) were 59-CGGCATTCCCACCAACTAC-39 (Forward) and 59-GGCCGGGCACAATCTG-39 (Reverse) [36]. Primers for other genes are available upon request. Total RNA was extracted from A549 cells with TRIZOL Reagent (Invitrogen). qRT-PCR was performed using 26QuantiTect SYBR Green PCR kit (Qiagen, Mississauga, Canada) on LightCycler480 (Roche, Mannheim, Germany) as described [37,38]. Each assay included a standard curve of five serial dilutions and a no-template negative control. The gene expression levels were normalized to the level of SDHA as a house-keeping gene.

Microarray and data analysis
For microarray study, four groups were prepared (i.e., cells treated with or without TNFa and in the presence of Claudin 1 siRNA or control siRNA) and were tested with three biological replicates for each group. Total RNA was extracted using RNeasy kit (Qiagen, Valencia, CA), and cDNA was synthesized with High-Capacity cDNA Reverse Transcription kits (Applied Biosystems, Foster City, CA) on a PTC-100 TM Programmable Thermal controller (MJ Research Inc., Watertown, MA). The RNA Integrity Number (RIN) was determined by Agilent Bioanalyzer 2100 (Agilent Technologies, Inc., Santa Clara, CA). Human Gene ST 1.0 chips (28,132 spotted genes) from Affymetrix (Santa Clara, CA) were used. Affymetrix CEL files were imported into Partek software (Partek Inc., St. Louis, MO) using the default Partek normalization parameters. Probe-level data were pre-processed with robust multi-array average (RMA) analyses, which include background correction, normalization, and summarization. Data normalization was performed across all arrays, using quartile normalization. The processed values were then compiled, or summarized, using the median polish technique, to generate a single measure of expression. Principle Component Analysis (PCA) was performed using Partek. Hierarchical cluster analysis was performed with significantly changed genes (p,0.001) using twoway ANOVA. Differential expression analysis was performed using Significance Analysis of Microarray (SAM) [40]. Signal transduction network was analyzed with Ingenuity Pathway Analysis (IPA)(Ingenuity Systems, Inc., Redwood City, CA) [36]. The original microarray data have been deposited to GEO Repository (accession number GSE 32254).

Wound-healing assay
Wounds were created in confluent cells using a pipette tip [28]. The cells were then rinsed with medium to remove floating cells and debris. TNFa and/or TGFb1 containing medium was added. To test the effects of serum and/or EGF on cell migration, after siRNA transfection confluent cells were serum starved before wounding. Cells were then treated with 10% FBS, and/or 50 ng/ ml EGF [41]. The culture plates were incubated at 37uC. Wounds were measured at 0, 6, 12 and 18 h. Assays were repeated four times for each condition.

Cell proliferation assay
The proliferation assays were performed to determine the effect of TNFa and/or TGFb1 on the cell growth over time as described previously [42]. In brief, A549 cells were seeded into 96-well cell culture plates at a density of 5610 3 cells/well and incubated for 48 h prior to the treatments. The medium was replaced with 100 ml fresh one containing 20 ng/ml TNFa and/or 10 ng/ml TGFb1. The assay was performed at 0, 8, 18 and 24 h after the treatments in quadruplicates with CellTiter 96 R AQueous One Solution Cell Proliferation Assay (Promega, Madison, WI). At each time point, 20 ml of the assay solution was added to each well and incubated for 1 h at 37uC. The plate was then read on a 96 well plate reader (ThermoLab system, Opsys MR) at 490 nm. The absorbance values were plotted as a function of time for each treatment to show the cell proliferation profile.

Gelatin zymography
The cell-conditioned media were diluted with sample buffer (5% SDS, 20% glycerol in 0.5 M Tris, pH 6.8, containing 0.02% bromophenol blue), and loaded in a 10% zymogram gel containing 0.1% gelatin (Sigma-Aldrich, St. Louis, MO) [27]. After electrophoresis, the gels were washed for 30 min in 2.5% Triton X-100 and incubated overnight at 37uC in 50 mM Tris, pH 7.4, 5 mM CaCl 2 , 0.02% Brij 35. The gels were stained with 0.5% Coomassie Blue R-250 in 50% methanol and 10% acetic acid overnight at room temperature on a rotary shaker. The gels were de-stained for 5 h in 50% methanol and 10% acetic acid. The areas where the staining was digested were identified.

Claudin 1-pcDNA transfection
Claudin 1-pcDNA3.1/V5-His plasmid was given by Dr. Patricia Pintor dos Reis and Dr. Suzanne Kamel-Reid (University of Toronto), and an empty-pcDNA3.1/V5-His plasmid was used as a negative control [25]. Cells were seeded in a 6-well plate at 5.0610 5 cells/well and incubated overnight at 37uC. Cells were transfected with 500 ng/well Claudin 1-pcDNA or empty-pcDNA plasmids using Lipofectamine TM 2000 reagent (Invitrogen). The media containing plasmids were replaced with fresh medium with or without TNFa at 24 h after transfection. For protein studies, the siRNA transfected cells were harvested at 48 h after transfection.

Statistical analysis
Statistical analyses were carried out using Tukey-Kramer HSD test. Differences are considered significant when the P value was less than 0.05. Statistical analyses were performed using JMP version 5 (SAS Institute Inc., Cary, NC).

Induction of EMT by TGFb1 and TNFa in human lung carcinoma A549 cells
To investigate EMT in human lung carcinoma A549 cells, we treated cells with TNFa (20 ng/ml) and TGFb1 (10 ng/ml) for 72 h. The combined treatment of TNFa and TGFb1 induced morphological changes characterized as fibroblast-like cells ( Figure 1A). Immunofluorescent staining demonstrated that the combined treatment with TNFa and TGFb1 reduced expression of E-Cadherin, and re-distributed E-Cadherin from surface membrane to more diffuse in the cytoplasm ( Figure 1B left panel). These changes were confirmed with confocal microscopy at higher magnification ( Figure 1C). The F-actin staining showed strong cortical staining in the control cells, whereas more stress fibers can be seen in elongated fibroblast-like cells after TGFb1 and TNFa treatment ( Figure 1B, middle panel). Western blotting revealed that TNFa and TGFb1 together decreased expressions of E-Cadherin and Occludin, typical epithelial adherens and TJ marker proteins, and increased expressions of Vimentin, a typical mesenchymal marker ( Figure 1D). Claudin 1, one of the epithelial TJ markers, however, was increased after TGFb1 and TNFa treatment ( Figure 1D).

TNFa induces morphologic alteration and Claudin 1 expression in A549 cells
To investigate the main signal that induces the morphologic alternation, we treated A549 cells with TNFa and/or TGFb1 for 72 h. The changes in cell morphology and F-actin structures were determined with phase contrast microscopy and F-actin staining. TNFa alone induced the fibroblast-like morphological change of the cells with formation of F-actin stress fibers, and reduced cell-tocell contact. On the other hand, TGFb1 alone did not induce these changes (Figure 2A).
To investigate whether the change in the morphology of the cells are associated with changes of EMT markers, we treated cells with TNFa, TGFb1, or the both. In untreated cells, the protein levels of E-Cadherin continued to increase from 24 h to 72 h. In TGFb1 treated cells, E-Cadherin levels were inhibited; the band was seen only at the 72 h. In TNFa treated cells, E-Cadherin protein was found at 48 h and 72 h groups at lower levels than untreated controls. The inhibitory effect was enhanced by the combined TNFa and TGFb1 treatment ( Figure 2B). Claudin 1 expression was increased by TNFa alone. TGFb1 alone slightly reduced Claudin 1 at 24 h and 48 h. The effects of the combined use of TNFa and TGFb1 on Claudin 1 levels were very similar to the effect of TNFa alone ( Figure 2B). In MDCK cells, TGFb1 decreased Claudin 1 expression in a time dependent fashion [15]. When we stimulated MDCK cells with TGFb1 (10 ng/ml), decreased Claudin 1 was also found ( Figure 2C), suggesting the less inhibitory of TGFb1 to Claudin 1 in A549 cells could be cell type specific. The basal expression level of Claudin 1 mRNA was increased in a time-dependent manner between 24 and 48 h, which was significantly enhanced by TNFa stimulation as determined by real-time quantitative RT-PCR ( Figure 2D).
Furthermore, immunofluorescent staining demonstrated that TNFa-induced Claudin 1 protein expression was mainly found in the cytoplasm and not at the boundary of cell-to-cell contacts ( Figure 3A). The cytosolic distribution of Claudin 1 was further demonstrated with confocal microscopy at higher magnification ( Figure 3B). Assembly of tight junctions recruits tight junction proteins into complexes; therefore, make them resistant to detergent-salt extractions. Conversely, disassembly of tight junction may result in internalization or diffuse cytoplasmic distribu- tion of tight junction proteins, making them more extractable with detergent salt solutions [34]. Thus, to further determine the distribution of Claudin 1, we used Triton-X100 extraction followed by western blotting. Claudin 1 was found mainly in Triton X-100 soluble cytoplasm fractions, and increased after 24 h of TNFa stimulation. In contrast, ZO-1 and Occludin (epithelial surface markers) were mainly found in Triton X-100 insoluble precipitates. GAPDH, a cytosolic protein was found mainly in Triton X-100 soluble fraction ( Figure 3C). Therefore, our results suggest that the increased Claudin 1 is not mainly in tight junction but diffusely distributed in the cytoplasm. Knocking down Claudin 1 with siRNA significantly blocked TNFa-induced gene expression To determine the role of Claudin 1 in TNFa related cellular functions, we used microarray to analyze gene expression profiles in cells treated with or without TNFa and in the presence of Claudin 1 siRNA or control siRNA. TNFa stimulation (20 ng/ml for 24 h) increased Claudin 1 mRNA expression, while Claudin 1 siRNA effectively reduced both basal level and TNFa-induced Claudin 1 gene expression ( Figure 4A). Interestingly, TNFa reduced Claudin 2 gene expression, which was not affected by Claudin 1 siRNA treatment. TNFa has no significant effects on other Claudin family members (Table S1). Principle Component Analysis (PCA) indicated that the overall gene expression patterns were clearly separated based on either the TNFa stimulation or Claudin 1 siRNA pre-treatments ( Figure 4B). Hierarchical cluster analysis showed that the down regulation of Claudin 1 with siRNA has a profound effect on the gene expression profile. A group of genes were up-regulated in Claudin 1 siRNA treated cells, and another group of genes were down-regulated, regardless of TNFa treatment ( Figure 4C).
As expected, TNFa stimulation altered expression of many genes. One group of genes was up-regulated by TNFa in both Control and Claudin 1 siRNA transfected cells ( Figure 4C, red arrow). However, another group of genes regulated by TNFa in Control siRNA transfected cells are less regulated in Claudin 1 siRNA transfected cells ( Figure 4C, blue arrow). Significance Analysis of Microarray (SAM) was performed to detect genes significantly changed by TNFa treatment, which is indicated by False Discovery Rate (FDR) q value less than 5.0% and fold change greater than 1.3. In control siRNA transfected cells, TNFa changed expression of 468 genes, of which 450 genes were upregulated, whereas only 18 genes were down-regulated. In contrast, in Claudin 1 siRNA transfected cells, only 123 genes were significantly changed by TNFa, and all of them were upregulated. The Venn diagram revealed that 353 of the genes altered by TNFa in Control siRNA transfected cells are not changed in Claudin 1 siRNA transfected cells. This means that knock-down of Claudin 1 blocked 75% of the TNFa-induced gene expression changes ( Figure 4D). The top 20 genes up-regulated by TNFa are listed in Table 1. The folds of changes were decreased in Claudin 1 siRNA treated group in most of these genes. The top 20 down-regulated genes by TNFa are listed in Table 2. None of them remains significantly changed in Claudin 1 siRNA treated group. Six genes from up-or down-regulated genes were verified with qRT-PCR. Similar trends between microarray and qRT-PCR were observed ( Figure 5). These results indicate that Claudin 1 plays an important role in mediating TNFa-induced gene expression.

Claudin 1 siRNA blocked TNFa-induced genes are related to cell migration
We further analyzed Bio-functions of the 353 genes, which were blocked by Claudin 1 siRNA (highlighted area with dots on Venn diagram in Figure 4D). Among these significantly changed genes,   (Table S2). Ingenuity Pathway Analysis shows that the top ranked functional networks blocked by Claudin 1 siRNA treatment are related to antigen presentation, cellular development, gene expression, cellular movement and cell death (Table 3). In two of these functional networks, NFkB is well connected as a central hub of multiple molecules. One of them is related to antigen presentation (data now shown) and another is related to inflammation ( Figure 6A, Table S3A). Recent studies have demonstrated that NFkB promotes EMT, migration and invasion in cancer cells [14,43,44]. In the functional network on Cellular Movement, MMP-9 is located in the center ( Figure 6B, Table S3B). MMP-9 is one of the most important proteases for human lung epithelial cell migration [27,45].

Claudin 1 is important for TNFa-induced cell migration in A549 cells
To determine whether Claudin 1 is involved in TNFa-induced cell migration, we first compared the role of TNFa and TGFb1 in cell migration with a wound-healing assay. TNFa plus TGFb1 treatment significantly increased motility in A549 cells ( Figure 7A and 7B). TNFa alone, but not TGFb1, increased wound closure as effectively as TNFa plus TGFb1 did ( Figure 7B). To determine the increased wound closure is due to increase cell proliferation and/ or migration, we examined the effects of TNFa and/or TGFb on cell proliferation with MTS assay. Neither or both of them affected cell proliferation within 24 h of treatment ( Figure 7C). Microarray and qRT-PCR demonstrated that TNFa increased MMP-9 gene expression. A gelatin zymography assay demonstrated that the level of active-MMP 9 was increased by TNFa treatment; while the levels of both pro-and active-MMP 2 had no dramatic changes ( Figure 7D). These results indicate that TNFa is responsible for increased cell migration. Transfection of cells with Claudin 1 siRNA effectively reduced both the basal and TNFa-induced expression of Claudin 1 mRNA (Table S1) and protein ( Figure 8C) levels and cell migration ( Figure 8A and 8B). Next, we transfected A549 cells with Claudin 1-pcDNA, which effectively enhanced cell migration ( Figure 8D and 8E). Western blotting confirmed that Claudin 1-pcDNA transfection increased the expression level of Claudin 1 protein ( Figure 8F). Collectively, these results indicate that Claudin 1 has important role in mediating TNFa-induced cell migration.
To determine whether the role of Claudin 1 in TNFa-induced cell migration is specific, cells were serum-starved for 3 h and then stimulated with 10% serum and/or EGF (50 ng/ml). Serum plus EGF significantly increased cell migration. Interestingly, Claudin 1 siRNA transfected cells showed significantly increased migration in either EGF or serum treated group. This is more significant in cells treated with both serum and EGF ( Figure 9A). We then performed western blotting, serum and/or EGF slightly increased Claudin 1 protein levels. Claudin 1 siRNA effectively reduced the levels of Claudin 1 ( Figure 9B). To test whether down-regulation of Claudin 1 can alter TNFa-induced cell morphology changes, cells were treated with control or Claudin 1 siRNA and stimulated with TNFa, and/or TGFb.Claudin 1 siRNA reduced the morpholog-ical changes induced by TNFa alone or by TNFa plus TGFb, and TGFb alone had little effects on stress fiber formation and cell morphology, as shown by F-actin staining ( Figure 9C).

Discussion
One of the novel findings of the present study is the evidence that in human lung cancer A549 cells TNFa alone induced morphological changes, stress fiber formation, cell migration and the alteration of gene expression. More importantly, we found that these cellular functions are largely mediated through the induction of Claudin 1.
TNFa is known to augment TGFb1-induced EMT in various cells [12,13,46,47]. To investigate EMT in A549 cells, we treated cells with TNFa, TGFb1 or in combination, and examined the morphological changes, cytoskeletal structure and expression of EMT markers. Through these experiments, we found that TNFa and TGFb1 may have different roles in these human lung cancer cells. TGFb1 is more effectively inhibiting expression of E-Cadherin, a marker for the differentiation of epithelial cells, whereas TNFa is more effective in increasing Claudin 1 expression and through Claudin 1 to mediate down-stream gene expression and cell migration. It has been shown that TNFa stimulated EMT of human colonic organoids [11], promoted EMT in renal carcinoma cells [48,49] and in human skin cells [50]. In A549 cells, TNFa alone induced cell morphological changes and cell migration. Although these changes are related to EMT, we do not have enough evidence to support TNFa alone induced EMT in this cell type.
Normally, Claudin 1 expresses in lung epithelial cells and regulates tight junction permeability [51]. Claudin 1 expression is generally known to be decreased by TNFa, and the decreased protein expression and protein redistribution of Claudin 1 lead to the decrease in the trans-epithelial electric resistance and the increase in the paracellular permeability of epithelial cells [52,53]. TNFa increased Claudin 1 expression in human pancreatic cancer cells [54], and in airway smooth muscle cells [55]. In the present study, TNFa strongly increased Claudin 1 expression in human lung cancer cells. The increased Claudin 1 is mainly in Tritonsoluble cytoplasm, not in the tight junction complex of Tritoninsoluble fraction. More importantly, knock-down of Claudin 1 blocked 75% of the TNFa-induced gene expression changes. Two of the top five TNFa-induced functional networks effectively blocked by Claudin 1 siRNA are related to NFkB. It has been shown that NFkB signaling is involved in EMT [14,43,44]. In the Table 1, we can see several cytokines and chemokines on the top of the gene list up-regulated by TNFa, such as CCL5, CCL2, IL-8, IL-6 and IL-1a. The folds of changes of these genes were significantly lower in Claudin 1 siRNA treated cells. In the NFkB related inflammatory signal network ( Figure 6A, Table S3A), genes encoding proteins related to inflammation can be identified, such as CXCL10 (chemokine CXC motif ligand 10), CSF2 (colony stimulating factor 2), PLA2G4A and PLA2G4C (phospholipase A2, group IV members), KLRK1 and KLRC3 (killer cell lectinlike receptor subfamily members), and S100A3 (S100 calcium binding protein A3). TNFa is one of the most important inflammatory mediators in tumorigenesis. Our results suggest that Claudin 1 may be a crucial mediator in TNFa-initiated inflammatory responses.
In the signal network related to cell migration, genes are centered on MMP-9 ( Figure 6B, Table S3B). Indeed, the gene expression, protein level and activity of MMP-9 were increased after TNFa stimulation. PLAT, PLAU and PLAUR (stands for plasminogen activator, tissue type, urokinase type and PLAU receptor, respectively) are among the genes blocked by Claudin 1 siRNA. They are important players in the cell migration. Collagen type IV alpha-1 (COL4A1) and nidogen-2 (NID2) are components of the basement membrane, and may play a role in cell interactions with extracellular matrix. Furthermore, over 100 genes listed in Table S2 are related to cellular movements, cell-tocell interaction, tumor morphology and cell morphology. These data indicate the importance of Claudin 1 in mediating TNFa related lung cancer cell migration. The increased expression of Claudin-1 in colon cancer cells resulted in increased tumor growth and metastasis in vivo, whereas the siRNA knock-down of Claudin 1 in metastatic colon cancer cells inhibited migration and invasion [23]. Similarly, Claudin 1 over-expression increased cell motility in oral squamous cell carcinoma, melanoma and hepatocellular carcinoma [24][25][26].
In contrast to these findings, in human lung cancer CL1-5 cells, over expression of Claudin 1 inhibited cell migration, whereas knockdown of Claudin 1 restored the migration and invasive ability of cells with stably transfection of Claudin 1 [56]. In the present study, Claudin 1 siRNA transfection enhanced cell migration stimulated by EGF and/or serum in A549 cells ( Figure 9). As a TJ protein Claudin 1 participates in the cell-tocell adhesion. Its down-regulation may reduce the TJs and thus, promote cell migration. TNFa-induced Claudin 1, on other hand is mainly in the cytoplasm, and is involved in TNFa-induced gene expression. Since many of these Claudin 1 dependent genes are related to cell movement and morphology, Claudin 1 may mediate TNFa-initiated cell migration with multiple mechanisms.
In summary, we found that TNFa stimulation induces the gene expression of Claudin 1 in human lung cancer cells, and the latter acts as the signal mediator to regulate gene expression and cell migration. Further study on this pathway may serve as a mean to develop a novel therapeutic target for cancer.